BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17235713)

  • 1. Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico.
    Oñate-Ocaña LF; Milán-Revollo G; Aiello-Crocifoglio V; Carrillo JF; Gallardo-Rincón D; Brom-Valladares R; Herrera-Goepfert R; Dueñas-González A
    Ann Surg Oncol; 2007 Apr; 14(4):1439-48. PubMed ID: 17235713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
    Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
    Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The choice of surgical therapy in adenocarcinoma of the cardia].
    Solerio D; Camandona M; Gasparri G; Casalegno PA; Raggio E; Dei Poli M
    Minerva Chir; 2005 Feb; 60(1):17-22. PubMed ID: 15902049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
    Feith M; Stein HJ; Siewert JR
    Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
    Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
    Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
    Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
    Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in 793 cases of gastric cancer in an oncologic referral center].
    Oñate-Ocaña LF; Aiello-Crocifoglio V; Mondragón Sánchez R; Ruiz Molina JM; Gallardo-Rincón D
    Rev Gastroenterol Mex; 1999; 64(3):114-21. PubMed ID: 10532138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.
    Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Hsu WH; Li AF; Lui WY
    Ann Surg Oncol; 2009 Dec; 16(12):3237-44. PubMed ID: 19636628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.
    Sauvanet A; Mariette C; Thomas P; Lozac'h P; Segol P; Tiret E; Delpero JR; Collet D; Leborgne J; Pradère B; Bourgeon A; Triboulet JP
    J Am Coll Surg; 2005 Aug; 201(2):253-62. PubMed ID: 16038824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New classification for adenocarcinoma of the esophagogastric junction in China].
    Bai JG; Dang CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):138-43. PubMed ID: 17344604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
    Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
    Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
    Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
    Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.